The CCP Model
We will not call this revolutionary. We will tell you exactly what each step does, and exactly which failure in the traditional model it was built to fix.
Step 01 — Before the patient travels
Every CCP case begins with an independent clinical review run on our proprietary validation discipline. Is the treatment necessary? Is the proposed pathway appropriate? Is the destination right for this specific patient? Most programmes skip this entirely; they approve cases on a request and a quote.
Traditional model flaw: approval without clinical scrutiny.
Step 02 — Before the destination is chosen
CCP benchmarks across MedDirect's network — 500+ hospital partners across 20+ countries developed over a decade. Selection is not based on the cheapest option or the most convenient. It is based on the right hospital for the patient, with the merits being documented beforehand.
Traditional model flaw: destination by familiarity, not by fit.
Step 03 — Before the flight is booked
A bundled case price is confirmed in writing before any travel is booked. Not an estimate. Not a guideline. A number that holds. The work to produce this number — supplier negotiation, scope confirmation, contingency boundaries — happens upstream, where leverage exists.
Traditional model flaw: approval on estimates, billing on actuals.
Step 04 — While the patient is abroad
A dedicated case manager. Real-time clinical updates. Invoice reconciliation against the pre-confirmed price, line by line. Every variance challenged. Every additional charge required to be justified before it enters the final bill.
Traditional model flaw: invoices arriving with charges no one pre-validated.
Step 05 — After the patient comes home — the step most programmes miss
Industry estimates suggest the majority of cross-border patients return home with no structured follow-up. Complications return as new claims. Nobody connects them to the original case. CCP continues after discharge: scheduled post-operative teleconsultation, structured rehabilitation through MedRehab, outcome tracking until full recovery.
Traditional model flaw: programmes that end at the hospital door.
Most insurers approve overseas budgets they cannot verify. The number arrives from a referring agent. There is no second opinion on the clinical case or the price. By the time the invoice lands, the leverage is gone.
A proprietary clinical and pricing validation discipline sits inside CCP — the part of the platform that brings sanity to the approval before it happens. The mechanics belong in a conversation, not on a website.
Book a Discovery CallMonthly Burn vs Budget
Begin a Conversation
The answer is usually the most expensive conversation a healthcare team has all year.
